EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Protein Disulfide Isomerase Endoplasmic Reticulum Protein 57 (ERp57) is Protective Against ALS-Associated Mutant TDP-43 in Neuronal Cells

Sonam Parakh, Emma R Perri, Marta Vidal, Zeinab Takalloo, Cyril J Jagaraj, Prachi Mehta, Shu Yang, Colleen J Thomas, Ian P Blair, Yuning Hong, Julie D Atkin

NeuroMolecular Medicine · 2024

DOI: 10.1007/s12017-024-08787-0 ↗

Kurz gefasst

Fachartikel in der Zeitschrift NeuroMolecular Medicine, 2024. Verfasst von Sonam Parakh und 10 weiteren Autor:innen. Beteiligte Einrichtung: Motor Neuron Disease Research Centre, Macquarie Medical School, Faculty of Medicine, Health and Human Sciences, Macquarie University, Sydney, 2109, A…. Hauptthemen laut MEDLINE: Protein Disulfide-Isomerases, Amyotrophic Lateral Sclerosis, DNA-Binding Proteins, Inclusion Bodies. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Health and Medical Research Council of Australia, Motor Neuron Disease Research Australia, The Dementia Australia Research Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Amyotrophic Lateral Sclerosis (ALS) is a severe neurodegenerative disease affecting motor neurons. Pathological forms of Tar-DNA binding protein-43 (TDP-43), involving its mislocalisation to the cytoplasm and the formation of misfolded inclusions, are present in almost all ALS cases (97%), and ~ 50% cases of the related condition, frontotemporal dementia (FTD), highlighting its importance in neurodegeneration. Previous studies have shown that endoplasmic reticulum protein 57 (ERp57), a member of the protein disulphide isomerase (PDI) family of redox chaperones, is protective against ALS-linked mutant superoxide dismutase (SOD1) in neuronal cells and transgenic SOD1 G93A mouse models. However, it remains unclear whether ERp57 is protective against pathological TDP-43 in ALS. Here, we demonstrate that ERp57 is protective against key features of TDP-43 pathology in neuronal cells. ERp57 inhibited the mislocalisation of TDP-43 M337V from the nucleus to the cytoplasm. In addition, ERp57 inhibited the number of inclusions formed by ALS-associated variant TDP-43 M337V and reduced the size of these inclusions. ERp57 was also protective against ER stress and induction of apoptosis. Furthermore, ERp57 modulated the steady-state expression levels of TDP-43. This study therefore demonstrates a novel mechanism of action of ERp57 in ALS. It also implies that ERp57 may have potential as a novel therapeutic target to prevent the TDP-43 pathology associated with neurodegeneration.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Protein Disulfide-IsomerasesAmyotrophic Lateral SclerosisDNA-Binding ProteinsInclusion BodiesHumansAnimalsMiceCell NucleusCytoplasmNeuronsSuperoxide Dismutase-1Mutation

Stichwörter der Autor:innen

ALS—Amyotrophic lateral sclerosisER stressERp57—Endoplasmic reticulum protein 57PDI—Protein disulphide isomeraseTDP-43 pathology

Substanzen

Protein Disulfide-IsomerasesDNA-Binding ProteinsTARDBP protein, humanPDIA3 protein, humanSuperoxide Dismutase-1

Autor:innen und Institutionen

  • Motor Neuron Disease Research Centre, Macquarie Medical School, Faculty of Medicine, Health and Human Sciences, Macquarie University, Sydney, 2109, Australia.
  • Department of Microbiology, Anatomy, Physiology and Pharmacology, School of Agriculture, Biomedicine and Environment, La Trobe University, Melbourne, VIC, 3086, Australia.
  • Centre for Cardiovascular Biology and Disease Research, La Trobe University, Melbourne, VIC, 3086, Australia.
  • La Trobe Institute for Molecular Science, La Trobe University, Melbourne, VIC, 3086, Australia.
  • Motor Neuron Disease Research Centre, Macquarie Medical School, Faculty of Medicine, Health and Human Sciences, Macquarie University, Sydney, 2109, Australia. julie.atkin@mq.edu.au.
  • La Trobe Institute for Molecular Science, La Trobe University, Melbourne, VIC, 3086, Australia. julie.atkin@mq.edu.au.

Förderung

  • National Health and Medical Research Council of Australia
  • Motor Neuron Disease Research Australia
  • The Dementia Australia Research Foundation
  • Macquarie University

Zitieren

APA

Parakh, S., Perri, E. R., Vidal, M., Takalloo, Z., Jagaraj, C. J., Mehta, P., Yang, S., Thomas, C. J., Blair, I. P., Hong, Y., & Atkin, J. D. (2024). Protein Disulfide Isomerase Endoplasmic Reticulum Protein 57 (ERp57) is Protective Against ALS-Associated Mutant TDP-43 in Neuronal Cells. NeuroMolecular Medicine. https://doi.org/10.1007/s12017-024-08787-0

Vancouver

Parakh S, Perri ER, Vidal M, Takalloo Z, Jagaraj CJ, Mehta P, et al. Protein Disulfide Isomerase Endoplasmic Reticulum Protein 57 (ERp57) is Protective Against ALS-Associated Mutant TDP-43 in Neuronal Cells. NeuroMolecular Medicine. 2024. doi:10.1007/s12017-024-08787-0

BibTeX
@article{Parakh2024,
  author = {Parakh, Sonam and Perri, Emma R and Vidal, Marta and Takalloo, Zeinab and Jagaraj, Cyril J and Mehta, Prachi and Yang, Shu and Thomas, Colleen J and Blair, Ian P and Hong, Yuning and Atkin, Julie D},
  title = {Protein Disulfide Isomerase Endoplasmic Reticulum Protein 57 (ERp57) is Protective Against ALS-Associated Mutant TDP-43 in Neuronal Cells},
  journal = {NeuroMolecular Medicine},
  year = {2024},
  doi = {10.1007/s12017-024-08787-0}
}
Kostenlos starten →